We are live on ! Find out more
BC

Broadfin Capital Portfolio holdings

AUM $747M
1-Year Est. Return 100.56%
This Fund
S&P 500
This Quarter Est. Return
+19.91%
1 Year Est. Return
+100.56%
3 Year Est. Return
+297.65%
5 Year Est. Return
+365.91%
10 Year Est. Return
–
AUM
$1.15B
AUM Growth
+$196M
Cap. Flow
+$54.1M
Cap. Flow %
4.71%
Top 10 Hldgs %
49.21%
Holding
84
New
12
Increased
28
Reduced
17
Closed
9

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$47.9M
2
AEGR
Aegerion Pharmaceuticals
AEGR
+$38.9M
3
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$18M
4
KND
Kindred Healthcare
KND
+$12.2M
5
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$12.1M

Top Sells

Rank Stock Value
1
AMAG
AMAG Pharmaceuticals
AMAG
+$33.9M
2
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$19.1M
3
IPXL
Impax Laboratories, Inc.
IPXL
+$15.6M
4
NTUS
Natus Medical Inc
NTUS
+$13.7M
5
CEMP
Cempra, Inc.
CEMP
+$10M

Sector Composition

Rank Sector Weight
1 Healthcare 83.26%
2 Consumer Discretionary 0.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKD icon
76
Brookdale Senior Living
BKD
$3.62B
– –
-303,000
Closed -$9.76M
STRR
77
DELISTED
Star Equity Holdings
STRR
– –
-6,650
Closed -$1.31M
RAD
78
DELISTED
Rite Aid Corporation
RAD
– –
-83,750
Closed -$8.11M
INFI
79
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-1,500
Closed -$495K
CCXI
80
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-800,000
Closed -$3.6M
NTUS
81
DELISTED
Natus Medical Inc
NTUS
– –
-464,915
Closed -$13.7M
TTPH
82
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-47,962
Closed -$19.1M
IPXL
83
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-658,929
Closed -$15.6M
LBMH
84
DELISTED
LIBERATOR MED HLDGS INC (NY)
LBMH
– –
-1,150,837
Closed -$3.6M
1 2 3
4

Similar funds

CBU
CIBC Bank USA Chicago, Illinois $756M AUM 24.68% 1-Year Est. Return
CONA
Capital One National Association New York $756M AUM
MP
Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return
SC
Selz Capital New York $570M AUM 35.56% 1-Year Est. Return
KGACF
Kopernik Global All-Cap Fund Tampa, Florida $558M AUM
BPWA
Beacon Pointe Wealth Advisors Newport Beach, California $543M AUM 23.61% 1-Year Est. Return
TRAM
Tuscan Ridge Asset Management Chicago, Illinois $984M AUM 25.8% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Broadfin Capital's Q4 2014 Portfolio in Review

As of Q4 2014, Broadfin Capital held 84 positions worth $1.15B, up 21% from $954M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Broadfin Capital deployed $54.1M of net new capital in Q4 2014, opening 12 new positions and adding to 28 existing holdings. Its largest new stake was SALIX PHARMACEUTICALS LTD DEL: 100,000 shares worth $11.5M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, up from 79% a quarter earlier, followed by Consumer Discretionary.

On the sell side, the largest reduction was AMAG Pharmaceuticals, an estimated $33.9M trimmed.

  • Broadfin Capital's largest Q4 2014 buy was SALIX PHARMACEUTICALS LTD DEL: 100,000 shares worth $11.5M.
  • Broadfin Capital added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2014, an estimated $47.9M increase.
  • Broadfin Capital's biggest Q4 2014 reduction was AMAG Pharmaceuticals, cutting an estimated $33.9M.
  • Broadfin Capital fully exited Tetraphase Pharmaceuticals, Inc. in Q4 2014, selling an estimated $19.1M.
  • Broadfin Capital's ten largest holdings make up 49% of its $1.15B portfolio in Q4 2014.
  • Broadfin Capital opened 12 new positions and closed 9 in Q4 2014.
  • Broadfin Capital's portfolio value rose 21% quarter-over-quarter to $1.15B.

Based on Broadfin Capital's 13F filing for Q4 2014, filed 17 Feb 2015.